Daliani DD - Search Results

1

Thalidomide/estramustine/paclitaxel in metastatic androgen-independent prostate cancer.

Mathew P, Logothetis CJ, Dieringer PY, Chen I, Pagliaro LC, Bekele BN, Zhou X, Daliani DD. Mathew P, et al. Among authors: daliani dd. Clin Genitourin Cancer. 2006 Sep;5(2):144-9. doi: 10.3816/CGC.2006.n.031. Clin Genitourin Cancer. 2006. PMID: 17026803 Clinical Trial.

2

The results of a phase II randomized trial comparing 5-fluorouracil and 5-fluorouracil plus alpha-interferon: observations on the design of clinical trials for androgen-independent prostate cancer.

Daliani DD, Eisenberg PD, Weems J, Lord R, Fueger R, Logothetis CJ. Daliani DD, et al. J Urol. 1995 May;153(5):1587-91. J Urol. 1995. PMID: 7536271 Clinical Trial.

3

Markers of androgen-independent progression of prostatic carcinoma.

Daliani D, Papandreou CN. Daliani D, et al. Semin Oncol. 1999 Aug;26(4):399-406. Semin Oncol. 1999. PMID: 10482182 Review.

4

Cyclophosphamide and carboplatin and selective consolidation in advanced seminoma.

Amato RJ, Millikan R, Daliani D, Wood L, Logothetis C, Pollack A. Amato RJ, et al. Clin Cancer Res. 2000 Jan;6(1):72-7. Clin Cancer Res. 2000. PMID: 10656434 Clinical Trial.

5

A Phase II trial of bryostatin-1 for patients with metastatic renal cell carcinoma.

Pagliaro L, Daliani D, Amato R, Tu SM, Jones D, Smith T, Logothetis C, Millikan R. Pagliaro L, et al. Cancer. 2000 Aug 1;89(3):615-8. Cancer. 2000. PMID: 10931461 Clinical Trial.

6

Development of angiogenesis inhibition as therapy for prostate cancer.

Daliani D. Daliani D. Oncology (Williston Park). 2000 Dec;14(12 Suppl 13):21-3. Oncology (Williston Park). 2000. PMID: 11204669 Review.

7

Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial.

Tu SM, Millikan RE, Mengistu B, Delpassand ES, Amato RJ, Pagliaro LC, Daliani D, Papandreou CN, Smith TL, Kim J, Podoloff DA, Logothetis CJ. Tu SM, et al. Lancet. 2001 Feb 3;357(9253):336-41. doi: 10.1016/S0140-6736(00)03639-4. Lancet. 2001. PMID: 11210994 Clinical Trial.

8

Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancer.

Logothetis CJ, Wu KK, Finn LD, Daliani D, Figg W, Ghaddar H, Gutterman JU. Logothetis CJ, et al. Clin Cancer Res. 2001 May;7(5):1198-203. Clin Cancer Res. 2001. PMID: 11350884 Clinical Trial.

9

Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.

Fizazi K, Prow DM, Do KA, Wang X, Finn L, Kim J, Daliani D, Papandreou CN, Tu SM, Millikan RE, Pagliaro LC, Logothetis CJ, Amato RJ. Fizazi K, et al. Br J Cancer. 2002 May 20;86(10):1555-60. doi: 10.1038/sj.bjc.6600272. Br J Cancer. 2002. PMID: 12085204 Free PMC article. Clinical Trial.

10

Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinoma.

Pagliaro LC, Millikan RE, Tu SM, Williams D, Daliani D, Papandreou CN, Logothetis CJ. Pagliaro LC, et al. J Clin Oncol. 2002 Jul 1;20(13):2965-70. doi: 10.1200/JCO.2002.11.114. J Clin Oncol. 2002. PMID: 12089226 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters